Skip to main content
OpenTrials

Clinical trial condition

Neurotoxicity

Explore clinical trials studying Neurotoxicity. Study availability and eligibility vary by location and protocol.

55 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Neurotoxicity trial results

Completed

Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate

NCT00018967

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +4 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 103 locations
View Trial Details
Completed

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

NCT01417507

Conditions
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, +22 more
Locations
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
View all 41 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

NCT00666484

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • University College Hospital - London London, England, United Kingdom
  • King's College Hospital London, England, United Kingdom
  • Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle upon Tyne, England, United Kingdom
View Trial Details
Completed

Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

NCT00112996

Conditions
Chemically-Induced Disorders, Nervous System Diseases, Neurotoxicity, +4 more
Locations
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • CCOP - Wichita Wichita, Kansas, United States
  • Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital Alexandria, Louisiana, United States
View all 13 locations
View Trial Details
Completed

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

NCT00028509

Conditions
Chemically-Induced Disorders, Long-term Effects Secondary to Cancer Therapy in Children, Nervous System Diseases, +3 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford Comprehensive Cancer Center - Stanford Stanford, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Miami Children's Hospital Miami, Florida, United States
View all 26 locations
View Trial Details
Completed

Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia

NCT00085176

Conditions
Chemically-Induced Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda, California, United States
  • Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 31 locations
View Trial Details
Completed

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

NCT00058071

Conditions
Chemically-Induced Disorders, Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, +17 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
View all 57 locations
View Trial Details

Related conditions